Bio-Sens Tech has developed a digital-enabled technology for accurate detection of insulin in saliva to be used in POC settings, in order to replace the current time-consuming and expensive insulin ELISA test.
Headquarters:
Australia
Company Type:
SME
Company size:
1-10 Employees
Year Founded:
2018 (7 years)
Address:
SYDNEY, NSW 2121, AU
LOW
spending power
